Acinar cell reprogramming: a clinically important target in pancreatic disease

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Percival AC, Slack JM. Analysis of pancreatic development using a cell lineage label. Exp. Cell Res. 247(1), 123–132 (1999).
  Medline CASGoogle Scholar
• 2 Pan FC, Bankaitis ED, Boyer D et al. Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 140(4), 751–764 (2013).•• By combining genetic lineage tracing and experimental pancreatitis models, this study identifies a population of PTF1A-expressing cells that maintain multipotent capabilities in the adult pancreas and give rise to acinar, duct and endocrine cell types.
  Medline CASGoogle Scholar
• 3 Li W, Nakanishi M, Zumsteg A et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. Elife 3, e01846 (2014).
  MedlineGoogle Scholar
• 4 Kopp JL, Von Figura G, Mayes E et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22(6), 737–750 (2012).
  Medline CASGoogle Scholar
• 5 Wallace K, Marek CJ, Currie RA, Wright MC. Exocrine pancreas trans-differentiation to hepatocytes‐‐a physiological response to elevated glucocorticoid in vivo. J. Steroid Biochem. Mol. Biol. 116(1–2), 76–85 (2009).
  Medline CASGoogle Scholar
• 6 Bonal C, Thorel F, Ait-Lounis A, Reith W, Trumpp A, Herrera PL. Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adipocytes in mice. Gastroenterology 136(1), 309–319 e309 (2009).
  Medline CASGoogle Scholar
• 7 Jensen JN, Cameron E, Garay MV, Starkey TW, Gianani R, Jensen J. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128(3), 728–741 (2005).
  Medline CASGoogle Scholar
• 8 Greer RL, Staley BK, Liou A, Hebrok M. Numb regulates acinar cell dedifferentiation and survival during pancreatic damage and acinar-to-ductal metaplasia. Gastroenterology 145(5), 1088–1097 e1088 (2013).
  Medline CASGoogle Scholar
• 9 Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455(7213), 627–632 (2008).
  Medline CASGoogle Scholar
• 10 De La OJ, Emerson LL, Goodman JL et al. Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc. Natl Acad. Sci. USA 105(48), 18907–18912 (2008).
  MedlineGoogle Scholar
• 11 Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morphol. 10, 622–640 (1962).
  Medline CASGoogle Scholar
• 12 Wu SY, Hsieh CC, Wu RR et al. Differentiation of pancreatic acinar cells to hepatocytes requires an intermediate cell type. Gastroenterology 138(7), 2519–2530 (2010).
  Medline CASGoogle Scholar
• 13 Mehmood R, Varga G, Mohanty SQ et al. Epigenetic reprogramming in mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis. PLoS ONE 9(1), e84182 (2014).
  MedlineGoogle Scholar
• 14 Alahari S, Mehmood R, Johnson CL, Pin CL. The absence of MIST1 leads to increased ethanol sensitivity and decreased activity of the unfolded protein response in mouse pancreatic acinar cells. PLoS ONE 6(12), e28863 (2011).
  Medline CASGoogle Scholar
• 15 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9), 1414–1431 (1998).
  Medline CASGoogle Scholar
• 16 Mccall M, Shapiro AM. Islet cell transplantation. Semin. Pediatr. Surg. 23(2), 83–90 (2014).
  MedlineGoogle Scholar
• 17 Baeyens L, Bonne S, Bos T et al. Notch signaling as gatekeeper of rat acinar-to-beta-cell conversion in vitro. Gastroenterology 136(5), 1750–1760 e1713 (2009).
  Medline CASGoogle Scholar
• 18 Pagliuca FW, Melton DA. How to make a functional beta-cell. Development 140(12), 2472–2483 (2013).
  Medline CASGoogle Scholar
• 19 Habbe N, Shi G, Meguid RA et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc. Natl Acad. Sci. USA 105(48), 18913–18918 (2008).
  Medline CASGoogle Scholar
• 20 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA. Cancer J. Clin. 63(1), 11–30 (2013).
  MedlineGoogle Scholar
• 21 Arda HE, Benitez CM, Kim SK. Gene regulatory networks governing pancreas development. Dev. Cell 25(1), 5–13 (2013).
  Medline CASGoogle Scholar
• 22 Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129(10), 2447–2457 (2002).
  Medline CASGoogle Scholar
• 23 Zhou Q, Law AC, Rajagopal J, Anderson WJ, Gray PA, Melton DA. A multipotent progenitor domain guides pancreatic organogenesis. Dev. Cell 13(1), 103–114 (2007).• One of the first studies to use a genetic lineage tracing model to show that all pancreatic cell types are derived from a multipotent progenitor cell. The study also indicates that this population transiently exists during development and that endocrine and duct cells share a closer developmental origin than duct and acinar cells.
  Medline CASGoogle Scholar
• 24 Esni F, Ghosh B, Biankin AV et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 131(17), 4213–4224 (2004).
  Medline CASGoogle Scholar
• 25 Cleveland MH, Sawyer JM, Afelik S, Jensen J, Leach SD. Exocrine ontogenies: on the development of pancreatic acinar, ductal and centroacinar cells. Semin. Cell Dev. Biol. 23(6), 711–719 (2012).
  Medline CASGoogle Scholar
• 26 Ahlgren U, Jonsson J, Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122(5), 1409–1416 (1996).
  Medline CASGoogle Scholar
• 27 Offield MF, Jetton TL, Labosky PA et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122(3), 983–995 (1996).
  Medline CASGoogle Scholar
• 28 Krapp A, Knofler M, Ledermann B et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 12(23), 3752–3763 (1998).
  Medline CASGoogle Scholar
• 29 Kawaguchi Y, Cooper B, Gannon M, Ray M, Macdonald RJ, Wright CV. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat. Genet. 32(1), 128–134 (2002).
  Medline CASGoogle Scholar
• 30 Burlison JS, Long Q, Fujitani Y, Wright CV, Magnuson MA. Pdx-1 and Ptf1a concurrently determine fate specification of pancreatic multipotent progenitor cells. Dev. Biol. 316(1), 74–86 (2008).
  Medline CASGoogle Scholar
• 31 Seymour PA, Freude KK, Tran MN et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc. Natl Acad. Sci. USA 104(6), 1865–1870 (2007).
  Medline CASGoogle Scholar
• 32 Kim SK, Melton DA. Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor. Proc. Natl Acad. Sci. USA 95(22), 13036–13041 (1998).
  Medline CASGoogle Scholar
• 33 Dichmann DS, Miller CP, Jensen J, Scott Heller R, Serup P. Expression and misexpression of members of the FGF and TGFbeta families of growth factors in the developing mouse pancreas. Dev. Dyn. 226(4), 663–674 (2003).
  Medline CASGoogle Scholar
• 34 Hebrok M, Kim SK, Melton DA. Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev. 12(11), 1705–1713 (1998).
  Medline CASGoogle Scholar
• 35 Shen CN, Marguerie A, Chien CY, Dickson C, Slack JM, Tosh D. All-trans retinoic acid suppresses exocrine differentiation and branching morphogenesis in the embryonic pancreas. Differentiation 75(1), 62–74 (2007).
  Medline CASGoogle Scholar
• 36 Afelik S, Jensen J. Notch signaling in the pancreas: patterning and cell fate specification. Wiley Interdiscip. Rev. Dev. Biol. 2(4), 531–544 (2013).
  Medline CASGoogle Scholar
• 37 Axelrod JD. Delivering the lateral inhibition punchline: it's all about the timing. Sci. Signal. 3(145), pe38 (2010).
  MedlineGoogle Scholar
• 38 Jensen J, Heller RS, Funder-Nielsen T et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 49(2), 163–176 (2000).
  Medline CASGoogle Scholar
• 39 Jensen J, Pedersen EE, Galante P et al. Control of endodermal endocrine development by Hes-1. Nat. Genet. 24(1), 36–44 (2000).
  Medline CASGoogle Scholar
• 40 Apelqvist A, Li H, Sommer L et al. Notch signalling controls pancreatic cell differentiation. Nature 400(6747), 877–881 (1999).
  Medline CASGoogle Scholar
• 41 Hald J, Hjorth JP, German MS, Madsen OD, Serup P, Jensen J. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev. Biol. 260(2), 426–437 (2003).
  Medline CASGoogle Scholar
• 42 Afelik S, Qu X, Hasrouni E et al. Notch-mediated patterning and cell fate allocation of pancreatic progenitor cells. Development 139(10), 1744–1753 (2012).
  Medline CASGoogle Scholar
• 43 Ahnfelt-Ronne J, Jorgensen MC, Klinck R et al. Ptf1a-mediated control of Dll1 reveals an alternative to the lateral inhibition mechanism. Development 139(1), 33–45 (2012).
  MedlineGoogle Scholar
• 44 Horn S, Kobberup S, Jorgensen MC et al. Mind bomb 1 is required for pancreatic beta-cell formation. Proc. Natl Acad. Sci. USA 109(19), 7356–7361 (2012).
  Medline CASGoogle Scholar
• 45 Shih HP, Kopp JL, Sandhu M et al. A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 139(14), 2488–2499 (2012).
  Medline CASGoogle Scholar
• 46 Kopinke D, Brailsford M, Pan FC, Magnuson MA, Wright CV, Murtaugh LC. Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. Dev. Biol. 362(1), 57–64 (2012).
  Medline CASGoogle Scholar
• 47 Masui T, Long Q, Beres TM, Magnuson MA, Macdonald RJ. Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex. Genes Dev. 21(20), 2629–2643 (2007).
  Medline CASGoogle Scholar
• 48 Fujikura J, Hosoda K, Kawaguchi Y et al. Rbp-j regulates expansion of pancreatic epithelial cells and their differentiation into exocrine cells during mouse development. Dev. Dyn. 236(10), 2779–2791 (2007).
  Medline CASGoogle Scholar
• 49 Von Figura G, Morris JPT, Wright CV, Hebrok M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut 63(4), 656–664 (2014).
  Medline CASGoogle Scholar
• 50 Hale MA, Swift GH, Hoang CQ et al. The nuclear hormone receptor family member NR5A2 controls aspects of multipotent progenitor cell formation and acinar differentiation during pancreatic organogenesis. Development 141(16), 3123–3133 (2014).
  Medline CASGoogle Scholar
• 51 Martinelli P, Canamero M, Del Pozo N, Madriles F, Zapata A, Real FX. Gata6 is required for complete acinar differentiation and maintenance of the exocrine pancreas in adult mice. Gut 62(10), 1481–1488 (2013).
  Medline CASGoogle Scholar
• 52 Ziv O, Glaser B, Dor Y. The plastic pancreas. Dev. Cell 26(1), 3–7 (2013).
  Medline CASGoogle Scholar
• 53 Solar M, Cardalda C, Houbracken I et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev. Cell 17(6), 849–860 (2009).
  Medline CASGoogle Scholar
• 54 Desai BM, Oliver-Krasinski J, De Leon DD et al. Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J. Clin. Invest. 117(4), 971–977 (2007).
  Medline CASGoogle Scholar
• 55 Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429(6987), 41–46 (2004).
  Medline CASGoogle Scholar
• 56 Wallace K, Fairhall EA, Charlton KA, Wright MC. AR42J-B-13 cell: an expandable progenitor to generate an unlimited supply of functional hepatocytes. Toxicology 278(3), 277–287 (2010).
  Medline CASGoogle Scholar
• 57 Al-Adsani A, Burke ZD, Eberhard D et al. Dexamethasone treatment induces the reprogramming of pancreatic acinar cells to hepatocytes and ductal cells. PLoS ONE 5(10), e13650 (2010).
  MedlineGoogle Scholar
• 58 Zhou J, Wang X, Pineyro MA, Egan JM. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48(12), 2358–2366 (1999).
  Medline CASGoogle Scholar
• 59 Yew KH, Prasadan KL, Preuett BL et al. Interplay of glucagon-like peptide-1 and transforming growth factor-beta signaling in insulin-positive differentiation of AR42J cells. Diabetes 53(11), 2824–2835 (2004).
  Medline CASGoogle Scholar
• 60 Yew KH, Hembree M, Prasadan K et al. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells. J. Biol. Chem. 280(37), 32209–32217 (2005).
  Medline CASGoogle Scholar
• 61 Minami K, Okuno M, Miyawaki K et al. Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc. Natl Acad. Sci. USA 102(42), 15116–15121 (2005).
  Medline CASGoogle Scholar
• 62 Baeyens L, Lemper M, Leuckx G et al. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat. Biotechnol. 32(1), 76–83 (2014).
  Medline CASGoogle Scholar
• 63 Hesselson D, Anderson RM, Stainier DY. Suppression of Ptf1a activity induces acinar-to-endocrine conversion. Curr. Biol. 21(8), 712–717 (2011).
  Medline CASGoogle Scholar
• 64 Houbracken I, De Waele E, Lardon J et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology 141(2), 731–741, 741 e731–734 (2011).• The first study to use a genetic lineage tracing system to show human acinar cells, like rodent acinar cells, have the ability to be reprogrammed into duct cells.
  MedlineGoogle Scholar
• 65 Herrera PL, Nepote V, Delacour A. Pancreatic cell lineage analyses in mice. Endocrine 19(3), 267–278 (2002).
  Medline CASGoogle Scholar
• 66 Perez-Mancera PA, Guerra C, Barbacid M, Tuveson DA. What we have learned about pancreatic cancer from mouse models. Gastroenterology 142(5), 1079–1092 (2012).
  MedlineGoogle Scholar
• 67 Rooman I, Real FX. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Gut 61(3), 449–458 (2012).
  MedlineGoogle Scholar
• 68 Ji B, Tsou L, Wang H et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology 137(3), 1072–1082, 1082 e1071–1076 (2009).
  Medline CASGoogle Scholar
• 69 Hingorani SR, Petricoin EF, Maitra A et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6), 437–450 (2003).
  Medline CASGoogle Scholar
• 70 Aguirre AJ, Bardeesy N, Sinha M et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17(24), 3112–3126 (2003).
  Medline CASGoogle Scholar
• 71 Kojima K, Vickers SM, Adsay NV et al. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res. 67(17), 8121–8130 (2007).
  Medline CASGoogle Scholar
• 72 Guerra C, Schuhmacher AJ, Canamero M et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11(3), 291–302 (2007).•• Showed the importance of pancreatic injury and inflammation to accelerating and enhancing PDAC in mouse models carrying a constitutively activated form of K-Ras.
  Medline CASGoogle Scholar
• 73 Carriere C, Young AL, Gunn JR, Longnecker DS, Korc M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382(3), 561–565 (2009).
  Medline CASGoogle Scholar
• 74 Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract. Res. Clin. Gastroenterol. 24(3), 349–358 (2010).
  MedlineGoogle Scholar
• 75 Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology 144(6), 1180–1193 (2013).
  MedlineGoogle Scholar
• 76 Zhou X, Liu Z, Jang F, Xiang C, Li Y, He Y. Autocrine Sonic hedgehog attenuates inflammation in cerulein-induced acute pancreatitis in mice via upregulation of IL-10. PLoS ONE 7(8), e44121 (2012).
  Medline CASGoogle Scholar
• 77 Slater SD, Williamson RC, Foster CS. Expression of transforming growth factor-beta 1 in chronic pancreatitis. Digestion 56(3), 237–241 (1995).
  Medline CASGoogle Scholar
• 78 Pinho AV, Rooman I, Reichert M et al. Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. Gut 60(7), 958–966 (2011).
  Medline CASGoogle Scholar
• 79 Johnson CL, Peat JM, Volante SN, Wang R, Mclean CA, Pin CL. Activation of protein kinase Cdelta leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1. J. Pathol. 228(3), 351–365 (2012).
  Medline CASGoogle Scholar
• 80 Kubisch CH, Logsdon CD. Secretagogues differentially activate endoplasmic reticulum stress responses in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292(6), G1804–1812 (2007).
  Medline CASGoogle Scholar
• 81 Kowalik AS, Johnson CL, Chadi SA, Weston JY, Fazio EN, Pin CL. Mice lacking the transcription factor Mist1 exhibit an altered stress response and increased sensitivity to caerulein-induced pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292(4), G1123–1132 (2007).
  Medline CASGoogle Scholar
• 82 Lugea A, Waldron RT, French SW, Pandol SJ. Drinking and driving pancreatitis: links between endoplasmic reticulum stress and autophagy. Autophagy 7(7), 783–785 (2011).
  MedlineGoogle Scholar
• 83 Iovanna JL. Redifferentiation and apoptosis of pancreatic cells during acute pancreatitis. Int. J. Pancreatol. 20(2), 77–84 (1996).
  Medline CASGoogle Scholar
• 84 Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 23(7), 781–783 (2009).
  Medline CASGoogle Scholar
• 85 Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157(1), 95–109 (2014).
  Medline CASGoogle Scholar
• 86 Kouzarides T. Chromatin modifications and their function. Cell 128(4), 693–705 (2007).
  Medline CASGoogle Scholar
• 87 Sangiorgi E, Capecchi MR. Bmi1 lineage tracing identifies a self-renewing pancreatic acinar cell subpopulation capable of maintaining pancreatic organ homeostasis. Proc. Natl Acad. Sci. USA 106(17), 7101–7106 (2009).
  Medline CASGoogle Scholar
• 88 Van Arensbergen J, Garcia-Hurtado J, Moran I et al. Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program. Genome Res. 20(6), 722–732 (2010).
  Medline CASGoogle Scholar
• 89 Xu CR, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS. Chromatin “prepattern” and histone modifiers in a fate choice for liver and pancreas. Science 332(6032), 963–966 (2011).•• Provides that first evidence that differences in histone modifications precede changes in gene expression linked to either pancreatic or liver development. For example, specific histone modifications that are linked to repression or activation are observed in cells destined to become hepatocytes prior to overt differentiation.
  Medline CASGoogle Scholar
• 90 Won KJ, Xu Z, Zhang X et al. Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells. Nucleic Acids Res. 40(17), 8199–8209 (2012).
  Medline CASGoogle Scholar
• 91 Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315–326 (2006).•• Genes that are marked by both active and repressive histone modifications are deemed to be bivalent in nature. This study showed genes that promote specific developmental fates are bivalently marked in ES cells, allowing for rapid activation in response to appropriate cues promoting differentiation.
  Medline CASGoogle Scholar
• 92 Hattori N, Niwa T, Kimura K, Helin K, Ushijima T. Visualization of multivalent histone modification in a single cell reveals highly concerted epigenetic changes on differentiation of embryonic stem cells. Nucleic Acids Res. 41(15), 7231–7239 (2013).
  Medline CASGoogle Scholar
• 93 Denissov S, Hofemeister H, Marks H et al. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant. Development 141(3), 526–537 (2014).
  Medline CASGoogle Scholar
• 94 Pekowska A, Benoukraf T, Zacarias-Cabeza J et al. H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J. 30(20), 4198–4210 (2011).
  Medline CASGoogle Scholar
• 95 Aday AW, Zhu LJ, Lakshmanan A, Wang J, Lawson ND. Identification of cis regulatory features in the embryonic zebrafish genome through large-scale profiling of H3K4me1 and H3K4me3 binding sites. Dev. Biol. 357(2), 450–462 (2011).
  Medline CASGoogle Scholar
• 96 Cao R, Wang L, Wang H et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298(5595), 1039–1043 (2002).
  Medline CASGoogle Scholar
• 97 Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14(2), 155–164 (2004).
  Medline CASGoogle Scholar
• 98 Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16(22), 2893–2905 (2002).
  Medline CASGoogle Scholar
• 99 Margueron R, Li G, Sarma K et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 32(4), 503–518 (2008).
  Medline CASGoogle Scholar
• 100 Chen H, Gu X, Su IH et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 23(8), 975–985 (2009).
  Medline CASGoogle Scholar
• 101 Xu CR, Li LC, Donahue G et al. Dynamics of genomic H3K27me3 domains and role of EZH2 during pancreatic endocrine specification. EMBO J. 33(19), 2157–2170 (2014).
  Medline CASGoogle Scholar
• 102 Chen S, Rasmuson-Lestander A. Regulation of the Drosophila engrailed gene by Polycomb repressor complex 2. Mech. Dev. 126(5–6), 443–448 (2009).
  Medline CASGoogle Scholar
• 103 Mallen-St Clair J, Soydaner-Azeloglu R, Lee KE et al. EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev. 26(5), 439–444 (2012).•• Targeted deletion of Ezh2 in the mouse pancreas affects the ability of acinar cells to progress to PanINs suggesting that the PRC2 complex plays a role in enhancing K-Ras initiation of PDAC.
  MedlineGoogle Scholar
• 104 Anderson RM, Bosch JA, Goll MG et al. Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev. Biol. 334(1), 213–223 (2009).
  Medline CASGoogle Scholar
• 105 Rai K, Nadauld LD, Chidester S et al. Zebra fish Dnmt1 and Suv39h1 regulate organ-specific terminal differentiation during development. Mol. Cell. Biol. 26(19), 7077–7085 (2006).
  Medline CASGoogle Scholar
• 106 Noel ES, Casal-Sueiro A, Busch-Nentwich E et al. Organ-specific requirements for Hdac1 in liver and pancreas formation. Dev. Biol. 322(2), 237–250 (2008).
  Medline CASGoogle Scholar
• 107 Farooq M, Sulochana KN, Pan X et al. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev. Biol. 317(1), 336–353 (2008).
  Medline CASGoogle Scholar
• 108 Zhou W, Liang IC, Yee NS. Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer. Cancer Biol. Ther. 11(7), 659–670 (2011).
  Medline CASGoogle Scholar
• 109 Phillips JM, Burgoon LD, Goodman JI. The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. Toxicol. Sci. 110(2), 319–333 (2009).
  Medline CASGoogle Scholar
• 110 Aithal MG, Rajeswari N. Role of Notch signalling pathway in cancer and its association with DNA methylation. J. Genet. 92(3), 667–675 (2013).
  Medline CASGoogle Scholar
• 111 Roy A, Basak NP, Banerjee S. Notch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis. Cell Death Dis. 3, e380 (2012).
  Medline CASGoogle Scholar
• 112 Grady T, Liang P, Ernst SA, Logsdon CD. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 113(6), 1966–1975 (1997).
  Medline CASGoogle Scholar
• 113 Chen X, Ji B, Han B, Ernst SA, Simeone D, Logsdon CD. NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response. Gastroenterology 122(2), 448–457 (2002).
  Medline CASGoogle Scholar
• 114 Johnson CL, Weston JY, Chadi SA et al. Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 137(5), 1795–1804 (2009).
  Medline CASGoogle Scholar
• 115 Iovanna JL, Lechene De La Porte P, Dagorn JC. Expression of genes associated with dedifferentiation and cell proliferation during pancreatic regeneration following acute pancreatitis. Pancreas 7(6), 712–718 (1992).
  Medline CASGoogle Scholar
• 116 Kubisch CH, Gukovsky I, Lugea A et al. Long-term ethanol consumption alters pancreatic gene expression in rats: a possible connection to pancreatic injury. Pancreas 33(1), 68–76 (2006).
  Medline CASGoogle Scholar
• 117 Zeng Y, Wang X, Zhang W, Wu K, Ma J. Hypertriglyceridemia aggravates ER stress and pathogenesis of acute pancreatitis. Hepatogastroenterology 59(119), 2318–2326 (2012).
  Medline CASGoogle Scholar
• 118 Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 276(5688), 565–570 (1978).
  Medline CASGoogle Scholar
• 119 Di Croce L, Helin K. Transcriptional regulation by Polycomb group proteins. Nat Struct. Mol. Biol. 20(10), 1147–1155 (2013).
  Medline CASGoogle Scholar
• 120 Fukuda A, Morris JPT, Hebrok M. Bmi1 is required for regeneration of the exocrine pancreas in mice. Gastroenterology 143(3), 821–831 e821–822 (2012).
  Medline CASGoogle Scholar
• 121 Martinez-Romero C, Rooman I, Skoudy A et al. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma. J. Pathol. 219(2), 205–213 (2009).
  Medline CASGoogle Scholar
• 122 Toll AD, Dasgupta A, Potoczek M et al. Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma. Hum. Pathol. 41(9), 1205–1209 (2010).
  Medline CASGoogle Scholar
• 123 Lee ST, Li Z, Wu Z et al. Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers. Mol. Cell 43(5), 798–810 (2011).
  Medline CASGoogle Scholar
• 124 Xu K, Wu ZJ, Groner AC et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 338(6113), 1465–1469 (2012).
  Medline CASGoogle Scholar
• 125 Ginjala V, Nacerddine K, Kulkarni A et al. BMI1 is recruited to DNA breaks and contributes to DNA damage-induced H2A ubiquitination and repair. Mol. Cell. Biol. 31(10), 1972–1982 (2011).
  Medline CASGoogle Scholar
• 126 Factor DC, Corradin O, Zentner GE et al. Epigenomic comparison reveals activation of “seed” enhancers during transition from naive to primed pluripotency. Cell Stem Cell 14(6), 854–863 (2014).•• Identified epigenetic changes at gene enhancer regions that predated changes in gene expression or changes in the differentiation status of stem cells. These changes reflect an epigenetic re-programming that predates actual cell reprogramming and suggests that epigenetic changes may initiate this process.
  Medline CASGoogle Scholar
• 127 Johnson CL, Mehmood R, Laing SW, Stepniak CV, Kharitonenkov A, Pin CL. Silencing of the Fibroblast Growth Factor 21 gene is an underlying cause of acinar cell injury in mice lacking MIST1. Am. J. Physiol. Endocrinol. Metab. 306(8), E916–E928 (2014).
  Medline CASGoogle Scholar
• 128 Pin CL, Rukstalis JM, Johnson C, Konieczny SF. The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. J. Cell Biol. 155(4), 519–530 (2001).
  Medline CASGoogle Scholar
• 129 Tan W, Li Y, Lim SG, Tan TM. miR-106b-25/miR-17–92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. World J. Gastroenterol. 20(20), 5962–5972 (2014).
  Medline CASGoogle Scholar
• 130 Jin Y, Tymen SD, Chen D et al. MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing. PLoS ONE 8(5), e64434 (2013).
  Medline CASGoogle Scholar
• 131 Aguda BD. Modeling microRNA-transcription factor networks in cancer. Adv. Exp. Med. Biol. 774, 149–167 (2013).
  Medline CASGoogle Scholar
• 132 Rebours V, Albuquerque M, Sauvanet A et al. Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas. PLoS ONE 8(9), e76229 (2013).
  Medline CASGoogle Scholar
• 133 De Waele E, Wauters E, Ling Z, Bouwens L. Conversion of Human Pancreatic Acinar Cells Toward a Ductal-Mesenchymal Phenotype and the Role of Transforming Growth Factor beta and Activin Signaling. Pancreas 43(7), 1083–1092 (2014).
  Medline CASGoogle Scholar
• 134 Blauer M, Sand J, Nordback I, Laukkarinen J. A novel 2-step culture model for long-term in vitro maintenance of human pancreatic acinar cells. Pancreas 43(5), 762–767 (2014).
  MedlineGoogle Scholar
• 135 Cosen-Binker LI, Lam PP, Binker MG, Reeve J, Pandol S, Gaisano HY. Alcohol/cholecystokinin-evoked pancreatic acinar basolateral exocytosis is mediated by protein kinase C alpha phosphorylation of Munc18c. J. Biol. Chem. 282(17), 13047–13058 (2007).
  Medline CASGoogle Scholar
• 136 Gukovskaya AS, Hosseini S, Satoh A et al. Ethanol differentially regulates NF-kappaB activation in pancreatic acinar cells through calcium and protein kinase C pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 286(2), G204–G213 (2004).
  Medline CASGoogle Scholar
• 137 Ding YX, Yang K, Chin WC. Ethanol augments elevated-[Ca2+]C induced trypsin activation in pancreatic acinar zymogen granules. Biochem. Biophys. Res. Commun. 350(3), 593–597 (2006).
  Medline CASGoogle Scholar
• 138 Matsubayashi H, Canto M, Sato N et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res. 66(2), 1208–1217 (2006).
  Medline CASGoogle Scholar
• 139 Zhao G, Qin Q, Zhang J et al. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer. Ann. Surg. Oncol. 20(Suppl. 3), S301–S311 (2013).
  MedlineGoogle Scholar
• 140 Sato N, Ueki T, Fukushima N et al. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 123(1), 365–372 (2002).
  Medline CASGoogle Scholar
• 141 Hong SM, Kelly D, Griffith M et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod. Pathol. 21(12), 1499–1507 (2008).
  Medline CASGoogle Scholar
• 142 He S, Wang F, Yang L et al. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS ONE 6(11), e27684 (2011).
  Medline CASGoogle Scholar
• 143 Simo-Riudalbas L, Melo SA, Esteller M. DNMT3B gene amplification predicts resistance to DNA demethylating drugs. Genes Chromosomes Cancer 50(7), 527–534 (2011).
  Medline CASGoogle Scholar
• 144 Zhang JJ, Zhu Y, Zhu Y et al. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma. Clin. Transl. Oncol. 14(2), 116–124 (2012).
  Medline CASGoogle Scholar
• 145 Li L, Li Z, Kong X et al. Down-regulation of MicroRNA-494 via Loss of SMAD4 Increases FOXM1 and beta-Catenin Signaling in Pancreatic Ductal Adenocarcinoma Cells. Gastroenterology 147(2), 485–497 e418 (2014).
  Medline CASGoogle Scholar
• 146 Ma C, Nong K, Wu B et al. miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. J. Exp. Clin. Cancer Res. 33, 54 (2014).
  MedlineGoogle Scholar
• 147 Dang Z, Xu WH, Lu P et al. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Int. J. Biol. Sci. 10(7), 733–745 (2014).
  Medline CASGoogle Scholar
• 148 Maftouh M, Avan A, Funel N et al. miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells. Nucleosides Nucleotides Nucleic Acids 33(4–6), 384–393 (2014).
  Medline CASGoogle Scholar
• 149 Steele CW, Oien KA, Mckay CJ, Jamieson NB. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Pancreas 40(8), 1165–1171 (2011).
  Medline CASGoogle Scholar
• 150 Li A, Omura N, Hong SM et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 70(13), 5226–5237 (2010).
  Medline CASGoogle Scholar
• 151 Varambally S, Cao Q, Mani RS et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322(5908), 1695–1699 (2008).
  Medline CASGoogle Scholar
• 152 Nakahara O, Takamori H, Iwatsuki M et al. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2. Ann. Surg. Oncol. 19(Suppl. 3), S565–S571 (2012).
  MedlineGoogle Scholar
• 153 Grochola LF, Greither T, Taubert HW et al. Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreas. Neoplasia 10(9), 973–976 (2008).
  Medline CASGoogle Scholar
• 154 Lucas AL, Frado LE, Hwang C et al. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer 120(13), 1960–1967 (2014).
  Medline CASGoogle Scholar
• 155 Hamidi T, Algul H, Cano CE et al. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J. Clin. Invest. 122(6), 2092–2103 (2012).
  Medline CASGoogle Scholar
• 156 Von Figura G, Fukuda A, Roy N et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat. Cell Biol. 16(3), 255–267 (2014).
  Medline CASGoogle Scholar
• 157 Chen S, Borowiak M, Fox JL et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem Biol. 5(4), 258–265 (2009).
  Medline CASGoogle Scholar
• 158 Annes JP, Ryu JH, Lam K et al. Adenosine kinase inhibition selectively promotes rodent and porcine islet beta-cell replication. Proc. Natl Acad. Sci. USA 109(10), 3915–3920 (2012).
  Medline CASGoogle Scholar
• 159 Zhang L, Farrell JJ, Zhou H et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138(3), 949–957 e941–947 (2010).
  Medline CASGoogle Scholar
• 160 Frampton AE, Giovannetti E, Jamieson NB et al. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Expert Rev. Mol. Diagn. 14(3), 267–271 (2014).
  Medline CASGoogle Scholar
• 161 Seo YJ, Muench L, Reid A et al. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain. Bioorg. Med. Chem. Lett. 23(24), 6700–6705 (2013).
  Medline CASGoogle Scholar
• 162 Tang W, Kuruvilla SA, Galitovskiy V, Pan ML, Grando SA, Mukherjee J. Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model. Am. J. Nucl. Med. Mol. Imaging 4(4), 324–332 (2014).
  Medline CASGoogle Scholar
• 163 Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS ONE 6(8), e24099 (2011).
  Medline CASGoogle Scholar
• 164 Zhang X, Zhao X, Fiskus W et al. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas. Cancer Cell 22(4), 506–523 (2012).
  Medline CASGoogle Scholar